180 Life Sciences Corp (ATNF)
US$ 15.26%
Price Chart
Key Statistics
Market Cap
$ 5.02M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
11.4K
52W High
$ 8.00
52W Low
$ 0.66
Dividend Yield
0.00%
Beta
0.24
Technicals
50-Day MA
1.0081
200-Day MA
1.6521
52 Week High
8
52 Week Low
0.658
About ATNF
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in .
Employees
N/A
Headquarters
Palo Alto, CA
CEO
Mr. Lloyd Blair Jordan L.L.B., M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg